USANA Health Sciences (NYSE:USNA) Shares Down 2.1% on Insider Selling

USANA Health Sciences, Inc. (NYSE:USNA) traded down 2.1% during mid-day trading on Friday following insider selling activity. The company traded as low as $29.79 and last traded at $29.73. 10,077 shares were traded during mid-day trading, a decline of 90% from the average session volume of 100,948 shares. The stock had previously closed at $30.37.

Specifically, insider Joshua Foukas sold 5,732 shares of the business’s stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $32.54, for a total transaction of $186,519.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider David Mulham Mulham sold 3,234 shares of the firm’s stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $32.98, for a total transaction of $106,657.32. Following the completion of the sale, the insider now directly owns 12,775 shares in the company, valued at $421,319.50. This represents a 20.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Sidoti lowered shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th. StockNews.com downgraded USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Finally, DA Davidson cut their price objective on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a report on Thursday, February 27th.

USANA Health Sciences Trading Down 4.4 %

The stock has a market capitalization of $553.41 million, a P/E ratio of 10.26, a price-to-earnings-growth ratio of 0.93 and a beta of 0.98. The stock’s fifty day moving average price is $32.67 and its two-hundred day moving average price is $36.01.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.49 by $0.15. The firm had revenue of $213.61 million for the quarter, compared to the consensus estimate of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. As a group, analysts expect that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Institutional Trading of USANA Health Sciences

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Pacer Advisors Inc. grew its holdings in USANA Health Sciences by 16.5% in the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock worth $20,638,000 after acquiring an additional 76,904 shares during the last quarter. Pzena Investment Management LLC grew its stake in shares of USANA Health Sciences by 7.5% in the third quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock worth $39,801,000 after purchasing an additional 72,977 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in USANA Health Sciences by 7.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock valued at $27,751,000 after purchasing an additional 55,059 shares during the period. Jane Street Group LLC raised its position in USANA Health Sciences by 330.0% during the 4th quarter. Jane Street Group LLC now owns 39,979 shares of the company’s stock valued at $1,435,000 after purchasing an additional 30,681 shares during the last quarter. Finally, Norges Bank purchased a new stake in USANA Health Sciences in the 4th quarter worth approximately $953,000. Institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.